Sign inGet started

Hodges Philip

Insider CIK 1705562 · NASDAQ:ALT Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
ALT Altimmune, Inc. A Award deriv2026-05-012026-05-0148,800— $048,800SEC↗
ALT Altimmune, Inc. A Award deriv2025-09-252025-09-2948,800— $048,800SEC↗
ALT Altimmune, Inc. A Award deriv2024-09-262024-09-3034,900— $034,900SEC↗
ALT Altimmune, Inc. A Award deriv2023-09-282023-09-2926,100— $026,100SEC↗
ALT Altimmune, Inc. A Award deriv2022-09-292022-09-3023,500— $023,500SEC↗
ALT Altimmune, Inc. A Award deriv2021-09-232021-09-2424,100— $024,100SEC↗
ALT Altimmune, Inc. S Sale2021-03-012021-03-016,000$16.08 $96.5K8,731SEC↗
ALT Altimmune, Inc. S Sale2020-12-012020-12-021,227$13.54 $16.6K0SEC↗
ALT Altimmune, Inc. S Sale2020-11-302020-12-022,500$12.00 $30.0K14,731SEC↗
ALT Altimmune, Inc. M Exercise deriv2020-09-242020-10-1616,850— $00SEC↗
ALT Altimmune, Inc. M Exercise2020-09-242020-10-1616,850— $036,306SEC↗
ALT Altimmune, Inc. A Award deriv2020-09-242020-09-2825,500— $025,500SEC↗
ALT Altimmune, Inc. A Award deriv2020-06-252020-06-2916,850— $016,850SEC↗
ALT Altimmune, Inc. A Award deriv2019-01-022019-01-0420,000— $020,000SEC↗
ALT Altimmune, Inc. J Other2017-10-172017-10-171,278,471— $00SEC↗
ALT Altimmune, Inc. A Award deriv2017-10-132017-10-1720,000— $020,000SEC↗
NASDAQ:ALT Altimmune, Inc. A Award2017-05-042017-05-0836,785— $036,785SEC↗
NASDAQ:ALT Altimmune, Inc. A Award2017-05-042017-05-081,278,471— $01,278,471SEC↗
NASDAQ:ALT Altimmune, Inc. A Award2017-05-042017-05-084,455— $04,455SEC↗